Stock listing
Mabwell (shanghai) Bioscience Co., Ltd. Class A
Selected listing: 688062 · SSE · CNY · CN
Mabwell (shanghai) Bioscience Co., Ltd. Class A (Shanghai:688062), Health Technology. Latest release Sep 29, 2026: (688062)"MABWELL (SHANGHAI) BIOSCIENCE CO.…
- Ticker
- Shanghai:688062
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Shanghai
- Currency
- CNY
About Mabwell (shanghai) Bioscience Co., Ltd. Class A
Mabwell (Shanghai) Bioscience Co., Ltd. is a public company based in China, trading under the ticker 688062. Mabwell focuses on biopharmaceuticals and aims to advance innovative therapies in the healthcare sector.
Latest news from Mabwell (shanghai) Bioscience Co., Ltd. Class A
(688062)"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on External Investment and Introduction of Investors to Lianwei Chuangyuan
September 28, 2026
"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on Resolutions of the 3rd Meeting of the 3rd Board of Directors
September 28, 2026
"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026
September 17, 2026
ERS 2026 | Mabwell Presents Phase Ib/IIa Clinical Results of Anti-ST2 Monoclonal Antibody 9MW1911 in COPD Patients
September 4, 2026
"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
September 1, 2026
Research Mabwell (shanghai) Bioscience Co., Ltd. Class A
Mabwell (shanghai) Bioscience Co., Ltd. Class A company profile
View the public company page for Mabwell (shanghai) Bioscience Co., Ltd. Class A on 6ix.
Mabwell (shanghai) Bioscience Co., Ltd. Class A news
Read company news and market updates connected to Mabwell (shanghai) Bioscience Co., Ltd. Class A.
Mabwell (shanghai) Bioscience Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Mabwell (shanghai) Bioscience Co., Ltd. Class A.